Key Insights

Highlights

Treatment Research

5 treatments under study, led by Continuous Glucose Monitoring Cgm

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2/3 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07880769Phase 2/3Not Yet Recruiting

Verapamil In Preclinical Type 1 Diabetes

Showing all 1 trials

Research Network

Common Treatments

  • Continuous Glucose Monitoring Cgm1
  • Blood Sampling1
  • Urine Collection1
  • Ekg And Cardiological Evaluation1
  • Verapamil1

Active Sponsors

  • Assistance Publique Hopitaux De Paris1
  • Assistance Publique - Hôpitaux de Paris1
  • Fondation Francophone pour la Recherche sur le Diabete1

Top Investigators

Related Conditions

  • Type 1 Diabetes1

Activity Timeline